Eris Lifesciences Ltd. - Research Center
540596 ERIS Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 13.60 | 13.59 | 13.58 | 13.58 | 13.75 |
| Share application money | - | 0.45 | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 2,208.29 | 1,904.51 | 1,561.89 | 1,286.12 | 1,142.26 |
| Loan funds | |||||
| Secured loans | 316.87 | - | - | - | - |
| Unsecured loans | - | - | - | - | - |
| Total | 2,538.76 | 1,918.56 | 1,575.47 | 1,299.70 | 1,156.01 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 976.89 | 708.68 | 662.73 | 669.50 | 536.14 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 79.07 | 66.68 | 78.41 | 68.86 | 52.29 |
| Net block | 897.81 | 642.00 | 584.32 | 600.64 | 483.85 |
| Capital work-in-progress | 0.34 | 2.98 | 1.56 | 4.37 | 2.73 |
| Investments | 996.52 | 777.72 | 531.37 | 320.30 | 580.47 |
| Net current assets | |||||
| Current assets, loans & advances | 888.98 | 727.71 | 637.56 | 557.81 | 403.33 |
| Less : current liabilities & provisions | 244.90 | 231.86 | 179.34 | 183.43 | 314.37 |
| Total net current assets | 644.08 | 495.85 | 458.22 | 374.39 | 88.96 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 2,538.76 | 1,918.56 | 1,575.47 | 1,299.70 | 1,156.01 |
| Notes: | |||||
| Book value of unquoted investments | 32.87 | 777.37 | 531.01 | 319.96 | 578.54 |
| Market value of quoted investments | 0.33 | 0.35 | 0.36 | 0.34 | 1.93 |
| Contingent liabilities | 26.23 | 27.23 | 21.21 | 15.81 | 15.29 |
| Number of equity sharesoutstanding (Lacs) | 1359.92 | 1359.30 | 1357.81 | 1357.81 | 1375.20 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis